Federico Salamone

Summary

Country: Italy

Publications

  1. ncbi Moro orange juice prevents fatty liver in mice
    Federico Salamone
    Department of Internal Medicine, University of Catania, Via Santa Sofia 78, Catania, Italy
    World J Gastroenterol 18:3862-8. 2012
  2. ncbi Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis
    Federico Salamone
    Department of Internal Medicine, University of Catania, Catania, Italy
    Transl Res 159:477-86. 2012
  3. ncbi Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis
    Federico Salamone
    Department of Internal Medicine, University of Catania, Catania, Italy
    Dig Liver Dis 44:334-42. 2012
  4. ncbi Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice
    Giovanni Li Volti
    Department of Internal Medicine, University of Catania, Catania, Italy
    Cardiovasc Diabetol 10:62. 2011
  5. ncbi The interaction of metabolic factors with HCV infection: does it matter?
    Elisabetta Bugianesi
    Department of Internal Medicine, University of Turin, Italy
    J Hepatol 56:S56-65. 2012
  6. ncbi Clinical challenges and images in GI. Intestinal Waldenström macroglobulinemia
    Federico Salamone
    Department of Internal Medicine, University of Catania, Catania, Italy
    Gastroenterology 134:920, 1276. 2008

Detail Information

Publications6

  1. ncbi Moro orange juice prevents fatty liver in mice
    Federico Salamone
    Department of Internal Medicine, University of Catania, Via Santa Sofia 78, Catania, Italy
    World J Gastroenterol 18:3862-8. 2012
    ..To establish if the juice of Moro, an anthocyanin-rich orange, may improve liver damage in mice with diet-induced obesity...
  2. ncbi Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis
    Federico Salamone
    Department of Internal Medicine, University of Catania, Catania, Italy
    Transl Res 159:477-86. 2012
    ..Silibinin treatment counteracts the progression of liver injury by modulating lipid homeostasis and suppressing oxidative stress-mediated lipotoxicity and NFkB activation in experimental NASH...
  3. ncbi Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis
    Federico Salamone
    Department of Internal Medicine, University of Catania, Catania, Italy
    Dig Liver Dis 44:334-42. 2012
    ..Nonalcoholic fatty liver disease is a chronic metabolic disorder with significant impact on cardiovascular and liver mortality...
  4. ncbi Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice
    Giovanni Li Volti
    Department of Internal Medicine, University of Catania, Catania, Italy
    Cardiovasc Diabetol 10:62. 2011
    ..In this study, we assessed the effect of silibinin, a widely used flavonolignan from milk thistle, on ADMA levels and endothelial dysfunction in db/db mice...
  5. ncbi The interaction of metabolic factors with HCV infection: does it matter?
    Elisabetta Bugianesi
    Department of Internal Medicine, University of Turin, Italy
    J Hepatol 56:S56-65. 2012
    ..Thus, targeted lifestyle and pharmacological measures are urgently warranted in chronic hepatitis C with metabolic alterations...
  6. ncbi Clinical challenges and images in GI. Intestinal Waldenström macroglobulinemia
    Federico Salamone
    Department of Internal Medicine, University of Catania, Catania, Italy
    Gastroenterology 134:920, 1276. 2008